Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Fanconi Anemia 1

Interventions

Cyclophosphamide 22fludarabine phosphate 18Busulfan 16Antilymphocyte Serum 15Radiotherapy 12Cyclosporine 11Cord Blood Stem Cell Transplantation 11Peripheral Blood Stem Cell Transplantation 10Melphalan 10Filgrastim 10Tacrolimus 9Mycophenolic Acid 9Methylprednisolone 9Methotrexate 9Etoposide 7Cytarabine 7Whole-Body Irradiation 6sargramostim 4Tretinoin 3Thalidomide 3Carboplatin 3venetoclax 2ruxolitinib 2Thiotepa 2Thioguanine 2Specimen Handling 2Sirolimus 2Rituximab 2Leucovorin 2Immunoenzyme Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic-Myeloproliferative Diseases × Chromatography × Classical hematology × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡